{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T11:34:47Z","timestamp":1787312087356,"version":"build-2736575974"},"reference-count":30,"publisher":"S. Karger AG","issue":"1-2","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.karger.com\/Services\/SiteLicenses"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.karger.com\/Services\/SiteLicenses"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacology"],"published-print":{"date-parts":[[2014]]},"abstract":"<jats:p>The purpose of this research was to describe the pharmacokinetic parameters of \u03b2-hydroxyphosphocarnitine (\u03b2-HPC; CAS No. 1220955-20-3) after a single oral dose in rats and rabbits as well as to assess the impact of 14 weeks of \u03b2-HPC (100 mg\/kg) treatment on the serum metabolites and liver enzymes, body weight, and hepatic steatosis of lean and obese Zucker &lt;i&gt;fa\/fa&lt;\/i&gt; rats. In the case of the rat and rabbit study, the \u03b2-HPC area under the curve, biological half-life, and clearance were 2,174.4 versus 3,128 \u03bcg&lt;b&gt;\u2219&lt;\/b&gt;h\/ml, 23.7 versus 8.87 h, and 13.9 versus 151.1 ml\/h in the rats versus the rabbits, respectively. The values for the time of maximal concentration were 0.58 versus 1.53 h, for the maximal concentration, they were 62.4 versus 221.4 \u03bcg\/ml, and for the absorption rate constant 0.02 versus 2.40 h&lt;sup&gt;-1&lt;\/sup&gt;, respectively. In the case of the Zucker &lt;i&gt;fa\/fa&lt;\/i&gt; rat study, \u03b2-HPC administered orally once a day reduced insulin, triglyceride, and cholesterol levels in the liver and serum; it also reduced weight gain and decreased liver steatosis in obese rats after 14 weeks. \u03b2-HPC could therefore potentially be used in the treatment of metabolic syndrome.<\/jats:p>","DOI":"10.1159\/000366205","type":"journal-article","created":{"date-parts":[[2014,9,15]],"date-time":"2014-09-15T02:56:05Z","timestamp":1410749765000},"page":"90-98","source":"Crossref","is-referenced-by-count":3,"title":["Pharmacokinetic and Pharmacological Effects of \u03b2-Hydroxyphosphocarnitine in Animal Models"],"prefix":"10.1159","volume":"94","author":[{"given":"Jorge","family":"Reyes-Esparza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brissa","family":"Mendoza-Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"De la Cruz-Cordero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel \u00c1ngel","family":"Duarte-V\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge Luis","family":"Rosado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lourdes","family":"Rodr\u00edguez-Fragoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"127","published-online":{"date-parts":[[2014,9,13]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.00862.2006"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1177\/011542650802300116"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2008.08.008"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.109.132522"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-6175.2007.06052.x"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1053\/meta.2000.6250"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1320.003"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/MOG.0b013e3283505a3b"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1080\/10426509108029443"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.farmac.2004.01.004"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/S0040-4020(01)00542-7"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.tet.2005.09.126"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1159\/000328772"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/bcpt.12019"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/S0957-4166(02)00159-3"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/1097-4644(20010101)80:1<1::AID-JCB10>3.0.CO;2-W"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-6363(01)00313-3"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200342110-00002"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1177\/0091270006292851"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1080\/17450390802611636"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-10324-7_2"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.19.1_Suppl.I110"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1113\/expphysiol.2011.064220"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1111\/j.1549-8719.2010.00020.x"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.5551\/jat.8466"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1038\/oby.2007.114"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2008.01017.x"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2009.719"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1186\/1758-5996-3-31"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/103731"}],"container-title":["Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.karger.com\/Article\/Pdf\/366205","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.karger.com\/Article\/Pdf\/366205","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T13:36:16Z","timestamp":1745415376000},"score":1,"resource":{"primary":{"URL":"https:\/\/karger.com\/article\/doi\/10.1159\/000366205"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":30,"journal-issue":{"issue":"1-2","published-online":{"date-parts":[[2014,9,1]]},"published-print":{"date-parts":[[2014,9,25]]}},"URL":"https:\/\/doi.org\/10.1159\/000366205","archive":["Portico"],"relation":{},"ISSN":["0031-7012","1423-0313"],"issn-type":[{"value":"0031-7012","type":"print"},{"value":"1423-0313","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]}}}